Both CVS and Walgreens are set to start carrying a drug that our guest, CompassCare CEO Jim Harden, believes could be a danger to women nationwide.
The pharmacy chains confirmed late last week that they are set to start selling mifepristone, or abortion pills, sometime within the next few weeks. Though the pills will require a prescription, they could be readily available to anyone that requests them through a doctor.
Though approved by the Food and Drug Administration years prior, there have been a number of legal battles against mifepristone. With this release, however, Harden believe this chemical coat hanger, as he calls it, will dominate the abortion industry, leaving in-person trips to clinics at record lows. Jim Harden joins us now to discuss the situation further.
Q&A:
- Why do you believe the Food and Drug Administration were so quick to grant Walgreens and CVS the ability to offer mifepristone with prescription?
- You’ve talked about the effects of mifepristone for years. What clinical evidence have you found that indicates it’s more deadly than the Food and Drug Administration let on?
- What kind of effect will the abortion battle have when it comes to the forthcoming Presidential election? Could this affect Joe Biden’s attempt to get a re-election?
- Will this announcement boost the growing pro-abortion side into attacking those who are pro-life? Including pregnancy centers?
- Tell us more about CompassCare and the service it provides to others.
- Where can people go to learn more about CompassCare and what your team is doing?
- Answer: They can visit our official website at CompassCareCommunity.com.
- Answer: They can visit our official website at CompassCareCommunity.com.
About James Harden
Rev. James Harden, a dedicated pro-life advocate and leader of CompassCare, is known for his outspoken views on medical ethics, executive leadership, and pro-life strategy. With a family of ten children and a strong moral compass, he believes in the adage, “Money follows morality.” Harden has been vocal about perceived corruption in federal law enforcement and public policy in post-Roe America. His predictions about the Dobbs decision in 2018 and the demise of the “Red Wave” in 2022 showcase his deep understanding of the political landscape.
CONTACT:
For further details or to arrange the interview, please contact Jerry McGlothlin at jerry@specialguests.com or 919-437-0001.
